The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Open accessThe DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator-activated receptors (PPARs) are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that regulate energy metabolism. Currently, three PPAR subtypes have been identified: PPARα, PPARγ, and PPARβ/δ. PPARα and PPARδ are highly expressed in oxidative tissues and regulate genes involved in substrate delivery and oxidative phosphorylation (OXPHOS) and regulation of energy homeostasis. In contrast, PPARγ is more important in lipogenesis and lipid synthesis, with highest expression levels in white adipose tissue (WAT). In addition to tissues regulating whole body energy homeostasis, PPARs are expressed in immune cells and have an emerging critical role in immune cell differentiation and fate commitment. In this review, we discuss the actions of PPARs in the function of the innate and the adaptive immune system and their implications in immune-mediated inflammatory conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kotla, S., & Rao, G. N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686865 · Cited by 28
RetractedThe hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519 · cited 1×
“The transcription factors Peroxisome proliferator activated receptors (PPARs) were discovered 30 years ago in rodents [1] and belong to the subfamily 1 of the nuclear hormone”
BackgroundMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091 · cited 1×
“Because Treg survival and function depends on lipid metabolism [74], the specific role of PPARs on Treg maintenance and function remains an open and intriguing question.”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
C/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
A unified nomenclature system for the nuclear receptor superfamily
(1999) · Cell · doi:10.1016/s0092-8674(00)80726-6 · Cited by 1,208
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
Grygiel-Górniak, B. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-17 · Cited by 1,079
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1
Haemmerle, G., Moustafa, T., Woelkart, G., Büttner, S., Schmidt, A., van de Weijer, T., Hesselink, M., Jaeger, D., Kienesberger, P. C., Zierler, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2439 · Cited by 761
Kang, K., Reilly, S. M., Karabacak, V., Gangl, M. R., Fitzgerald, K., Hatano, B., & Lee, C.-H. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.002 · Cited by 699
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Wang, H., Franco, F., Tsui, Y.-C., Xie, X., Trefny, M. P., Zappasodi, R., Mohmood, S. R., Fernández-García, J., Tsai, C.-H., Schulze, I., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0589-5 · Cited by 672
An overview on biological mechanisms of PPARs
KOTA, B., HUANG, T., & ROUFOGALIS, B. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.07.012 · Cited by 666
Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
Michelet, X., Dyck, L., Hogan, A., Loftus, R. M., Duquette, D., Wei, K., Beyaz, S., Tavakkoli, A., Foley, C., Donnelly, R., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0251-7 · Cited by 621
Zhang, Y., Kurupati, R., Liu, L., Zhou, X. Y., Zhang, G., Hudaihed, A., Filisio, F., Giles-Davis, W., Xu, X., Karakousis, G. C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.004 · Cited by 616
Schneider, C., Nobs, S. P., Kurrer, M., Rehrauer, H., Thiele, C., & Kopf, M. (2014) · Nature Immunology · doi:10.1038/ni.3005 · Cited by 614
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Dutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537
Desnutrin/ATGL Is Regulated by AMPK and Is Required for a Brown Adipose Phenotype
Ahmadian, M., Abbott, M. J., Tang, T., Hudak, C. S. S., Kim, Y., Bruss, M., Hellerstein, M. K., Lee, H.-Y., Samuel, V. T., Shulman, G. I., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.05.002 · Cited by 525
Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., & Latruffe, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16710 · Cited by 524
The role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
Rahaman, S. O., Lennon, D. J., Febbraio, M., Podrez, E. A., Hazen, S. L., & Silverstein, R. L. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.007 · Cited by 506
Szanto, A., Balint, B. L., Nagy, Z. S., Barta, E., Dezso, B., Pap, A., Szeles, L., Poliska, S., Oros, M., Evans, R. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.009 · Cited by 448
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
Strauss, L., Mahmoud, M. A. A., Weaver, J. D., Tijaro-Ovalle, N. M., Christofides, A., Wang, Q., Pal, R., Yuan, M., Asara, J., Patsoukis, N., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aay1863 · Cited by 437
Self-citationWelch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., & Glass, C. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031789100 · Cited by 429
Chamoto, K., Chowdhury, P. S., Kumar, A., Sonomura, K., Matsuda, F., Fagarasan, S., & Honjo, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620433114 · Cited by 413
Mechanism of the nuclear receptor molecular switch
NAGY, L. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.04.006 · Cited by 410
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Distinct but complementary contributions of PPAR isotypes to energy homeostasis
Dubois, V., Eeckhoute, J., Lefebvre, P., & Staels, B. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88894 · Cited by 383
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
Mukundan, L., Odegaard, J. I., Morel, C. R., Heredia, J. E., Mwangi, J. W., Ricardo-Gonzalez, R. R., Goh, Y. P. S., Eagle, A. R., Dunn, S. E., Awakuni, J. U. H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2048 · Cited by 368
Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., Alferink, J., Novak, N., Beyer, M., Mayer, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082771 · Cited by 354
Chowdhury, P. S., Chamoto, K., Kumar, A., & Honjo, T. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0095 · Cited by 353
Patsouris, D., Reddy, J. K., Müller, M., & Kersten, S. (2006) · Endocrinology · doi:10.1210/en.2005-1132 · Cited by 340
Ong, K. T., Mashek, M. T., Bu, S. Y., Greenberg, A. S., & Mashek, D. G. (2011) · Hepatology · doi:10.1002/hep.24006 · Cited by 339
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi, P., Xu, M., & Spiegelman, B. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119715 · Cited by 314
Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282
Luo, W., Xu, Q., Wang, Q., Wu, H., & Hua, J. (2017) · Scientific Reports · doi:10.1038/srep44612 · Cited by 282
The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages
Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108482200 · Cited by 268
Macrophage polarization: the link between inflammation and related diseases
Bashir, S., Sharma, Y., Elahi, A., & Khan, F. (2016) · Inflammation Research · doi:10.1007/s00011-015-0874-1 · Cited by 267
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Cheng, H. S., Tan, W. R., Low, Z. S., Marvalim, C., Lee, J. Y. H., & Tan, N. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205055 · Cited by 264
Angela, M., Endo, Y., Asou, H. K., Yamamoto, T., Tumes, D. J., Tokuyama, H., Yokote, K., & Nakayama, T. (2016) · Nature Communications · doi:10.1038/ncomms13683 · Cited by 259
PPAR Agonists and Metabolic Syndrome: An Established Role?
Botta, M., Audano, M., Sahebkar, A., Sirtori, C., Mitro, N., & Ruscica, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041197 · Cited by 253
Garcia-Roves, P., Huss, J. M., Han, D.-H., Hancock, C. R., Iglesias-Gutierrez, E., Chen, M., & Holloszy, J. O. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704024104 · Cited by 246 · cited 1×
“Dietary lipids activate PPAR, as evidenced by the increased expression of PPARα target genes in the liver and PPARβ/δ target genes in the skeletal muscle induced by high-fat diet (HFD) in mice [19,20].”
BackgroundShiri-Sverdlov, R., Wouters, K., Gorp, P. J. V., Gijbels, M. J., Noel, B., Buffat, L., Staels, B., Maeda, N., Bilsen, M. V., & Hofker, M. H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.033 · Cited by 241
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K.-J., Gao, Y., Bennett, M. V. L., et al. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 236
Tachibana, K., Yamasaki, D., Ishimoto, K., & Doi, T. (2008) · PPAR Research · doi:10.1155/2008/102737 · Cited by 223
Zhang, M. A., Rego, D., Moshkova, M., Kebir, H., Chruscinski, A., Nguyen, H., Akkermann, R., Stanczyk, F. Z., Prat, A., Steinman, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118458109 · Cited by 218
Dunn, S. E., Ousman, S. S., Sobel, R. A., Zuniga, L., Baranzini, S. E., Youssef, S., Crowell, A., Loh, J., Oksenberg, J., & Steinman, L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061839 · Cited by 210
Daub, K., Langer, H., Seizer, P., Stellos, K., May, A. E., Goyal, P., Bigalke, B., Schönberger, T., Geisler, T., Siegel‐Axel, D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6265fje · Cited by 207
Genetic Modulation of PPARγ Phosphorylation Regulates Insulin Sensitivity
Rangwala, S. M., Rhoades, B., Shapiro, J. S., Rich, A. S., Kim, J. K., Shulman, G. I., Kaestner, K. H., & Lazar, M. A. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00274-0 · Cited by 204
Ribon, V., Johnson, J. H., Camp, H. S., & Saltiel, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14751 · Cited by 196
Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation
Stienstra, R., Mandard, S., Patsouris, D., Maass, C., Kersten, S., & Müller, M. (2007) · Endocrinology · doi:10.1210/en.2007-0014 · Cited by 191
PPAR dual agonists: Are they opening Pandora's Box?
BALAKUMAR, P., ROSE, M., GANTI, S., KRISHAN, P., & SINGH, M. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.03.002 · Cited by 190
Yue, T.-L., Bao, W., Jucker, B. M., Gu, J.-L., Romanic, A. M., Brown, P. J., Cui, J., Thudium, D. T., Boyce, R., Burns-Kurtis, C. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093187.42015.6c · Cited by 189
Varga, T., Mounier, R., Patsalos, A., Gogolák, P., Peloquin, M., Horvath, A., Pap, A., Daniel, B., Nagy, G., Pintye, E., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.016 · Cited by 187
Cipolletta, D., Cohen, P., Spiegelman, B. M., Benoist, C., & Mathis, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423486112 · Cited by 186
Appel, S., Mirakaj, V., Bringmann, A., Weck, M. M., Grünebach, F., & Brossart, P. (2005) · Blood · doi:10.1182/blood-2004-12-4709 · Cited by 185
Yu, S., Rao, S., & Reddy, J. K. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479537 · Cited by 184
Takano, H., Nagai, T., Asakawa, M., Toyozaki, T., Oka, T., Komuro, I., Saito, T., & Masuda, Y. (2000) · Circulation Research · doi:10.1161/01.res.87.7.596 · Cited by 181
Daniel, B., Nagy, G., Czimmerer, Z., Horvath, A., Hammers, D. W., Cuaranta-Monroy, I., Poliska, S., Tzerpos, P., Kolostyak, Z., Hays, T. T., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.005 · Cited by 178
Rőszer, T., Menéndez-Gutiérrez, M. P., Lefterova, M. I., Alameda, D., Núñez, V., Lazar, M. A., Fischer, T., & Ricote, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002230 · Cited by 177
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases
Choi, J.-M., & Bothwell, A. L. M. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2297-y · Cited by 176
Festuccia, W. T., Laplante, M., Berthiaume, M., Gélinas, Y., & Deshaies, Y. (2006) · Diabetologia · doi:10.1007/s00125-006-0336-y · Cited by 168
Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase
Chandak, P. G., Radović, B., Aflaki, E., Kolb, D., Buchebner, M., Fröhlich, E., Magnes, C., Sinner, F., Haemmerle, G., Zechner, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107854 · Cited by 163
Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells
Fan, Y., Wang, Y., Tang, Z., Zhang, H., Qin, X., Zhu, Y., Guan, Y., Wang, X., Staels, B., Chien, S., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.149815 · Cited by 163
Fibrates and future PPARα agonists in the treatment of cardiovascular disease
Staels, B., Maes, M., & Zambon, A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1278 · Cited by 160
Zhang, J., Cheng, Y., Gu, J., Wang, S., Zhou, S., Wang, Y., Tan, Y., Feng, W., Fu, Y., Mellen, N., et al. (2016) · Clinical Science · doi:10.1042/cs20150623 · Cited by 159
Heming, M., Gran, S., Jauch, S.-L., Fischer-Riepe, L., Russo, A., Klotz, L., Hermann, S., Schäfers, M., Roth, J., & Barczyk-Kahlert, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00893 · Cited by 155
Transcriptional Regulatory Circuits Controlling Brown Fat Development and Activation
Seale, P. (2015) · Diabetes · doi:10.2337/db15-0203 · Cited by 154
Nobs, S. P., Natali, S., Pohlmeier, L., Okreglicka, K., Schneider, C., Kurrer, M., Sallusto, F., & Kopf, M. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162069 · Cited by 154
PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism
Kim, Y. S., Lee, H.-M., Kim, J. K., Yang, C.-S., Kim, T. S., Jung, M., Jin, H. S., Kim, S., Jang, J., Oh, G. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601920 · Cited by 151
Al-Khami, A. A., Hossain, F., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Del Valle, L., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 150
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
Régnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouché, E., Lasserre, F., Naylies, C., Bétoulières, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63579-3 · Cited by 140
INT131: A Selective Modulator of PPARγ
Motani, A. S., Wang, Z., Weiszmann, J., McGee, L. R., Lee, G., Liu, Q., Staunton, J., Fang, Z., Fuentes, H., Lindström, M., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.025 · Cited by 137
Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells
Fu, S., He, K., Tian, C., Sun, H., Zhu, C., Bai, S., Liu, J., Wu, Q., Xie, D., Yue, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14332-x · Cited by 134
SMITH, U., GOGG, S., JOHANSSON, A., OLAUSSON, T., ROTTER, V., & SVALSTEDT, B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0020com · Cited by 132
Human “T H 9” cells are a subpopulation of PPAR-γ + T H 2 cells
Micossé, C., von Meyenn, L., Steck, O., Kipfer, E. T., Adam, C., Simillion, C., Jafari, S. M. S., Oláh, P., Yawalkar, N., Simon, D., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aat5943 · Cited by 131
Penas, F., Mirkin, G., Vera, M. S., Cevey, Á., Gonzalez, C., Gómez, M. I., Sales, M., & Goren, N. (2015) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2014.12.019 · Cited by 127
PPAR-γ promotes type 2 immune responses in allergy and nematode infection
Chen, T., Tibbitt, C. A., Feng, X., Stark, J. M., Rohrbeck, L., Rausch, L., Sedimbi, S. K., Karlsson, M. C. I., Lambrecht, B. N., Hedestam, G. B. K., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aal5196 · Cited by 123
Klotz, L., Dani, I., Edenhofer, F., Nolden, L., Evert, B., Paul, B., Kolanus, W., Klockgether, T., Knolle, P., & Diehl, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2122 · Cited by 122
Wang, L., Teng, R., Di, L., Rogers, H., Wu, H., Kopp, J. B., & Noguchi, C. T. (2013) · Diabetes · doi:10.2337/db13-0518 · Cited by 122
Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
Gou, Q., Gong, X., Jin, J., Shi, J., & Hou, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19610 · Cited by 112
Aprahamian, T., Bonegio, R. G., Richez, C., Yasuda, K., Chiang, L.-K., Sato, K., Walsh, K., & Rifkin, I. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.340 · Cited by 100
Dai, M., Wu, L., He, Z., Zhang, S., Chen, C., Xu, X., Wang, P., Gruzdev, A., Zeldin, D. C., & Wang, D. W. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24939 · Cited by 99
Askari, V. R., & Shafiee-Nick, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.12.059 · Cited by 98
Shan, W., Palkar, P. S., Murray, I. A., McDevitt, E. I., Kennett, M. J., Kang, B. H., Isom, H. C., Perdew, G. H., Gonzalez, F. J., & Peters, J. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn142 · Cited by 97
Dunn, S. E., Bhat, R., Straus, D. S., Sobel, R. A., Axtell, R., Johnson, A., Nguyen, K., Mukundan, L., Moshkova, M., Dugas, J. C., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091663 · Cited by 97
Wu, L., Yan, C., Czader, M., Foreman, O., Blum, J. S., Kapur, R., & Du, H. (2012) · Blood · doi:10.1182/blood-2011-06-363093 · Cited by 93
Kotla, S., Singh, N. K., & Rao, G. N. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.005 · Cited by 92
Park, J., Lee, S. E., Hur, J., Hong, E. B., Choi, J.-I., Yang, J.-M., Kim, J.-Y., Kim, Y.-C., Cho, H.-J., Peters, J. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.024 · Cited by 91
Khan, M. A., Alam, Q., Haque, A., Ashafaq, M., Khan, M. J., Ashraf, G. M., & Ahmad, M. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180828100002 · Cited by 91
Adhikary, T., Wortmann, A., Schumann, T., Finkernagel, F., Lieber, S., Roth, K. S., Toth, P. M., Diederich, W. E., Nist, A., Stiewe, T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv331 · Cited by 90
Kanakasabai, S., Chearwae, W., Walline, C. C., Iams, W., Adams, S. M., & Bright, J. J. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03261.x · Cited by 87
Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
Li, S., Mariappan, N., Megyesi, J. K., Shank, B. B., Kannan, K., Theus, S. A., Price, P. M., Duffield, J. S., & Portilla, D. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2013 · Cited by 86
Serrano-Marco, L., Rodríguez-Calvo, R., El Kochairi, I., Palomer, X., Michalik, L., Wahli, W., & Vázquez-Carrera, M. (2011) · Diabetes · doi:10.2337/db10-0704 · Cited by 78
Saibil, S. D., Paul, M. S., Laister, R. C., Garcia-Batres, C. R., Israni-Winger, K., Elford, A. R., Grimshaw, N., Robert-Tissot, C., Roy, D. G., Jones, R. G., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-17-3053 · Cited by 78
Nielsen, R., Grøntved, L., Stunnenberg, H. G., & Mandrup, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02266-05 · Cited by 77
Iwaki, T., Bennion, B. G., Stenson, E. K., Lynn, J. C., Otinga, C., Djukovic, D., Raftery, D., Fei, L., Wong, H. R., Liles, W. C., et al. (2019) · Physiological Reports · doi:10.14814/phy2.14078 · Cited by 77
Li, Y., Wang, Z., Furukawa, N., Escaron, P., Weiszmann, J., Lee, G., Lindstrom, M., Liu, J., Liu, X., Xu, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800104200 · Cited by 75
Coll, T., Rodríguez‐Calvo, R., Barroso, E., Serrano, L., Eyre, E., Palomer, X., & Vázquez‐Carrera, M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010046 · Cited by 75
Kino, T., Rice, K. C., & Chrousos, G. P. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01796.x · Cited by 74
Crisafulli, C., & Cuzzocrea, S. (2009) · Shock · doi:10.1097/shk.0b013e31818bbad6 · Cited by 74
Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases
Balint, B., & Nagy, L. (2006) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006776056620 · Cited by 74
Jin, L., Hasegawa, H., Matsumoto, T., & Yasukawa, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001437 · Cited by 74
Song, J., Choi, S., & Kim, B. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00064 · Cited by 71
Zhou, L., Yu, M., Arshad, M., Wang, W., Lu, Y., Gong, J., Gu, Y., Li, P., & Xu, L. M. (2018) · Diabetes · doi:10.2337/db17-1452 · Cited by 71
Pedersen, G., & Brynskov, J. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.749 · Cited by 69
Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis
Wang, J., Song, J., Li, Y., Shao, J., Xie, Z., & Sun, K. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105933 · Cited by 68
Lee, H. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i45.12787 · Cited by 67
Lee, M. Y., Choi, R., Kim, H. M., Cho, E. J., Kim, B. H., Choi, Y. S., Naowaboot, J., Lee, E. Y., Yang, Y. C., Shin, J. Y., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.10.066 · Cited by 64
El-Haggar, S. M., & Mostafa, T. M. (2015) · Hepatology International · doi:10.1007/s12072-015-9633-1 · Cited by 61
Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 61
Bouhlel, M. A., Brozek, J., Derudas, B., Zawadzki, C., Jude, B., Staels, B., & Chinetti, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.047 · Cited by 57
Hucke, S., Floßdorf, J., Grützke, B., Dunay, I. R., Frenzel, K., Jungverdorben, J., Linnartz, B., Mack, M., Peitz, M., Brüstle, O., et al. (2012) · Brain · doi:10.1093/brain/aws058 · Cited by 57
T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
Tong, M., Deochand, C., Didsbury, J., & de la Monte, S. M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151013 · Cited by 55
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
Heidari, Z., Chrisman, I. M., Nemetchek, M. D., Novick, S. J., Blayo, A., Patton, T. M., Mendes, D. E., Diaz, P., Kamenecka, T. M., Griffin, P. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13768-0 · Cited by 52
Wang, W., Lin, Q., Lin, R., Zhang, J., Ren, F., Zhang, J., Ji, M., & Li, Y. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.007 · Cited by 51
Bojic, L. A., Sawyez, C. G., Telford, D. E., Edwards, J. Y., Hegele, R. A., & Huff, M. W. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.255208 · Cited by 51
PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis
Yang, Y., Gocke, A. R., Lovett‐Racke, A. E., Drew, P. D., & Racke, M. K. (2008) · PPAR Research · doi:10.1155/2008/546753 · Cited by 50
Kanakasabai, S., Walline, C. C., Chakraborty, S., & Bright, J. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.059 · Cited by 50
Perilipin 3 Deficiency Stimulates Thermogenic Beige Adipocytes Through PPARα Activation
Lee, Y. K., Sohn, J. H., Han, J. S., Park, Y. J., Jeon, Y. G., Ji, Y., Dalen, K. T., Sztalryd, C., Kimmel, A. R., & Kim, J. B. (2018) · Diabetes · doi:10.2337/db17-0983 · Cited by 48
Zhao, T., Du, H., Blum, J. S., & Yan, C. (2015) · Oncotarget · doi:10.18632/oncotarget.6414 · Cited by 47
Lian, M., Luo, W., Sui, Y., Li, Z., & Hua, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132741 · Cited by 46
Zhang, M. A., Ahn, J. J., Zhao, F. L., Selvanantham, T., Mallevaey, T., Stock, N., Correa, L. D., Clark, R., Spaner, D., & Dunn, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500449 · Cited by 45
Gilardi, F., Giudici, M., Mitro, N., Maschi, O., Guerrini, U., Rando, G., Maggi, A. C., Cermenati, G., Laghezza, A., Loiodice, F., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506394 · Cited by 44
Xu, Y., Kume, S., Tanaka, Y., Isshiki, K., Araki, S., Chin‒Kanasaki, M., Sugimoto, T., Koya, D., Haneda, M., Sugaya, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025271 · Cited by 43
Toffoli, B., Gilardi, F., Winkler, C., Söderberg, M. P., Kowalczuk, L., Arsenijévic, Y., Bamberg, K., Bonny, O., & Desvergne, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171474 · Cited by 43
Wittrisch, S., Klöting, N., Mörl, K., Chakaroun, R., Blüher, M., & Beck‐Sickinger, A. G. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.009 · Cited by 41
Choi, K. C., Lee, S. Y., Yoo, H. J., Ryu, O., Lee, K. W., Kim, S. M., Baik, S. H., & Choi, K. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.114 · Cited by 40
Nandhikonda, P., Yasgar, A., Baranowski, A. M., Sidhu, P. S., McCallum, M. M., Pawlak, A. J., Teske, K. A., Feleke, B., Yuan, N. Y., Kevin, C., et al. (2013) · Biochemistry · doi:10.1021/bi400321p · Cited by 40
Guo, K., Hu, L., Xi, D., Zhao, J., Liu, J., Luo, T., Ma, Y., Lai, W., & Guo, Z. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.01.013 · Cited by 40
Patil, R., Mohanty, B., Liu, B., Chandrashekaran, I. R., Headey, S. J., Williams, M. L., Clements, C. S., Ilyichova, O. V., Doak, B. C., Genissel, P., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006848 · Cited by 39
Cutting Edge: Dual Function of PPARγ in CD11c+ Cells Ensures Immune Tolerance in the Airways
Khare, A., Chakraborty, K., Raundhal, M. R., Ray, P., & Ray, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500474 · Cited by 37
Chen, K., Li, J., Wang, J., Xia, Y., Dai, W., Wang, F., Shen, M., Cheng, P., Zhang, Y., Wang, C., et al. (2014) · PPAR Research · doi:10.1155/2014/215631 · Cited by 37
Romero, M., Toral, M., Robles‐Vera, I., Sánchez, M., Jiménez, R., O’Valle, F., Rodríguez‐Nogales, A., Pérez‐Vizcaíno, F., Gálvez, J., & Duarte, J. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08655 · Cited by 37
PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF
Goyal, G., Wong, K. K. W., Nirschl, C. J., Souders, N. C., Neuberg, D. S., Anandasabapathy, N., & Dranoff, G. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0612 · Cited by 36
Wang, D., Ning, W., Xie, D., Guo, L., & DuBois, R. N. (2011) · Oncogene · doi:10.1038/onc.2011.299 · Cited by 35
Metabolic influence on the differentiation of suppressive myeloid cells in cancer
Porta, C., Marino, A., Consonni, F. M., Bleve, A., Mola, S., Storto, M., Riboldi, E., & Sica, A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy088 · Cited by 32
Wogonin suppresses osteopontin expression in adipocytes by activating PPARα
Zhang, Y., Li, M., Tang, Z., & Wang, C. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.37 · Cited by 31
A role for Peroxisome Proliferator-Activated Receptor Beta in T cell development
Mothe‐Satney, I., Murdaca, J., Sibille, B., Rousseau, A., Squillace, R., Menn, G. L., Rekima, A., Larbret, F., Pelé, J., Verhasselt, V., et al. (2016) · Scientific Reports · doi:10.1038/srep34317 · Cited by 30
Quantitative PPARγ expression affects the balance between tolerance and immunity
Liu, Y.-H., Tsai, Y.-S., Lin, S., Liao, N., Jan, M., Liang, C.-T., Hsu, S.-W., Chen, W.-C., Sung, J., Maeda, N., et al. (2016) · Scientific Reports · doi:10.1038/srep26646 · Cited by 28
Teruel, T., Clapham, J. C., & Smith, S. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1526 · Cited by 27
JAZF1 regulates visfatin expression in adipocytes via PPARα and PPARβ/δ signaling
Ming, G.-F., Li, X., Yin, J., Ai, Y., Xu, D., Ma, X., Liu, Z., Liu, H., Zhou, H.-H., & Liu, Z. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.006 · Cited by 26
Dubrac, S., Elentner, A., Schoonjans, K., Auwerx, J. H., & Schmuth, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041357 · Cited by 26
Waldén, T. B., Petrovič, N., & Nedergaard, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.053 · Cited by 25
Teruel, T., Smith, S. A., Peterson, J. J., & Clapham, J. C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2982 · Cited by 24
Wolf, G. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.nov.387-390 · Cited by 23
Liang, Y., Chen, S.-A., & Jian, J.-H. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.03.011 · Cited by 22
Lanatoside C Promotes Foam Cell Formation and Atherosclerosis
Shi, H., Mao, X., Zhong, Y., Liu, Y., Zhao, X., Yu, K., Zhu, R., Wei, Y., Zhu, J., Sun, H., et al. (2016) · Scientific Reports · doi:10.1038/srep20154 · Cited by 21
Chang, J. S., & Ha, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195007 · Cited by 21
Zhu, Y., Ni, Y.-Y., Liu, R., Hou, M., Yang, B.-Y., Song, J., Sun, H.-Z., Xu, Z.-P., & Ji, M. (2018) · Journal of Immunological Research · doi:10.1155/2018/6398078 · Cited by 21
Drohomyrecky, P. C., Doroshenko, E. R., Akkermann, R., Moshkova, M., Yi, T. J., Zhao, F. L., Ahn, J. J., McGaha, T. L., Pahan, K., & Dunn, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801200 · Cited by 21
Hichami, A., Yessoufou, A., Ghiringhelli, F., Salvadori, F., Moutairou, K. A., Zwetyenga, N., & Khan, N. A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.09.001 · Cited by 19
Zhao, F. L., Ahn, J. J., Chen, E. L. Y., Yi, T. J., Stickle, N. H., Spaner, D., Zúñiga‐Pflücker, J. C., & Dunn, S. E. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800374 · Cited by 19
Godoy, J. A., Zolezzi, J. M., & Inestrosa, N. C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.146 · Cited by 13
Sohn, K.-A. K., Cruciani‐Guglielmacci, C., Kassis, N., Clément, L., Ouali, F., Caüzac, M., Lebègue, N., Berthelot, P., Caignard, D., Pégorier, J. P., et al. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.033 · Cited by 12
Peroxisome proliferator‐activated receptor‐β/δ modulates mast cell phenotype
Yao, P., Morales, J. L., Gonzalez, F. J., & Peters, J. M. (2016) · Immunology · doi:10.1111/imm.12699 · Cited by 11
Huang, X., Ren, L., Ye, P., Cheng, C., Wu, J., Wang, S., Sun, Y., Liu, Z., Xie, A., & Xia, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112953 · Cited by 9
Stafeev, I., Michurina, S. S., Zubkova, E., Beloglazova, I. B., Ratner, E. I., Парфенова, Е. В., & Menshikov, M. Y. (2018) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-018-4186-7 · Cited by 8
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport
Michaelis, M., Rothweiler, F., Wurglics, M., Aniceto, N., Dittrich, M., Zettl, H., Wiese, M., Wass, M. N., Ghafourian, T., Schubert‐Zsilavecz, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7345 · Cited by 7
Cited by
The complex role of tumor-infiltrating macrophages
Christofides, A., Strauss, L., Yeo, A., Cao, C., Charest, A., & Boussiotis, V. A. (2022) · Nature Immunology · doi:10.1038/s41590-022-01267-2 · Cited by 849
Self-citationConsideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)
Ehrlich, V., Bil, W., Vandebriel, R., Granum, B., Luijten, M., Lindeman, B., Grandjean, P., Kaiser, A.-M., Hauzenberger, I., Hartmann, C., et al. (2023) · Environmental Health · doi:10.1186/s12940-022-00958-5 · Cited by 318
Update on Anti-Inflammatory Molecular Mechanisms Induced by Oleic Acid
Santa-María, C., López-Enríquez, S., Montserrat-de la Paz, S., Geniz, I., Reyes-Quiroz, M. E., Moreno, M., Palomares, F., Sobrino, F., & Alba, G. (2023) · Nutrients · doi:10.3390/nu15010224 · Cited by 300
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Traber, G. M., & Yu, A.-M. (2023) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001234 · Cited by 291
Qiu, Y.-Y., Zhang, J., Zeng, F.-Y., & Zhu, Y. Z. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106786 · Cited by 271
Metadata
- Authors
- Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 114
- Pages
- 154338
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W3048549881
- Cited by
- 720
- References
- 185
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.